Last mentioned: Mar 11, 2026
30-Year Review Publication
Comprehensive review paper summarizing three decades of data is published in a peer-reviewed journal.
Barycel Launch
GC Biopharma launches an improved version of its varicella vaccine based on the MAV/06 strain.
Global Expansion
The MAV/06-based vaccine is exported to over 30 countries and integrated into national immunization programs.
Initial Development
GC Biopharma begins the clinical application of the MAV/06 varicella strain.
GC Biopharma has published a comprehensive review paper detailing three decades of clinical and real-world data for its proprietary MAV/06 varicella vaccine strain. This publication underscores the long-term safety and efficacy of the strain, which has been a cornerstone of the company's global vaccine portfolio and international procurement strategy.
This page surfaces every story mentioning MAV/06 across our biotech coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.
Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running biotech beat. Cross-entity comparisons live on our compare view.
| What you see | What it tells you |
|---|---|
| Story count | Number of distinct stories where MAV/06 was a primary or referenced actor. |
| Recency clustering | Whether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc). |
| Sentiment distribution | Aggregate sentiment of the stories mentioning this entity, weighted by impact score. |
| Cross-niche links | When the same entity surfaces in our sibling networks, we link to those views to enrich context. |